1. Home
  2. PTCT vs AXTA Comparison

PTCT vs AXTA Comparison

Compare PTCT & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.77

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Axalta Coating Systems Ltd.

AXTA

Axalta Coating Systems Ltd.

HOLD

Current Price

$27.85

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
AXTA
Founded
1998
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Paints/Coatings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.9B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
PTCT
AXTA
Price
$66.77
$27.85
Analyst Decision
Buy
Buy
Analyst Count
16
14
Target Price
$80.94
$35.92
AVG Volume (30 Days)
1.0M
2.5M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
N/A
EPS
7.78
1.74
Revenue
$264,734,000.00
$5,117,000,000.00
Revenue This Year
N/A
$3.56
Revenue Next Year
$21.65
$2.93
P/E Ratio
$8.29
$15.86
Revenue Growth
36.19
N/A
52 Week Low
$35.95
$26.28
52 Week High
$87.50
$35.72

Technical Indicators

Market Signals
Indicator
PTCT
AXTA
Relative Strength Index (RSI) 46.23 21.99
Support Level $61.43 $27.43
Resistance Level $68.44 $31.01
Average True Range (ATR) 2.62 0.96
MACD 0.19 -0.52
Stochastic Oscillator 55.17 6.75

Price Performance

Historical Comparison
PTCT
AXTA

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.

Share on Social Networks: